![Molecules | Free Full-Text | New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells Molecules | Free Full-Text | New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells](https://pub.mdpi-res.com/molecules/molecules-28-00446/article_deploy/html/images/molecules-28-00446-ag-550.jpg?1672917151)
Molecules | Free Full-Text | New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells
![Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019) Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)](https://jnccn.org/view/journals/jnccn/17/11.5/inline-jnccn20195034f2.jpg)
Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)
![Enzymatic hydrolysis by transition-metal-dependent nucleophilic aromatic substitution | Nature Chemical Biology Enzymatic hydrolysis by transition-metal-dependent nucleophilic aromatic substitution | Nature Chemical Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnchembio.2191/MediaObjects/41589_2016_Article_BFnchembio2191_Fig1_HTML.jpg)
Enzymatic hydrolysis by transition-metal-dependent nucleophilic aromatic substitution | Nature Chemical Biology
![These highlights do not include all the information needed to use OGIVRI safely and effectively. See full prescribing information for OGIVRI. OGIVRI® (trastuzumab-dkst) for injection, for intravenous use Initial U.S. Approval: 2017 These highlights do not include all the information needed to use OGIVRI safely and effectively. See full prescribing information for OGIVRI. OGIVRI® (trastuzumab-dkst) for injection, for intravenous use Initial U.S. Approval: 2017](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=image-09.jpg&id=553789)
These highlights do not include all the information needed to use OGIVRI safely and effectively. See full prescribing information for OGIVRI. OGIVRI® (trastuzumab-dkst) for injection, for intravenous use Initial U.S. Approval: 2017
![Emodin | CAS:518-82-1 | Naturally occurring anthraquinone,antiproliferative | Anthraquinones | High Purity | Manufacturer BioCrick Emodin | CAS:518-82-1 | Naturally occurring anthraquinone,antiproliferative | Anthraquinones | High Purity | Manufacturer BioCrick](https://www.biocrick.com/media/images/struct/BCN5649.png)
Emodin | CAS:518-82-1 | Naturally occurring anthraquinone,antiproliferative | Anthraquinones | High Purity | Manufacturer BioCrick
![WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents](https://patentimages.storage.googleapis.com/56/9a/57/d17b5497ecf0c6/imgf000027_0001.png)
WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents
![Pharmacy | Free Full-Text | Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases Pharmacy | Free Full-Text | Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases](https://www.mdpi.com/pharmacy/pharmacy-08-00059/article_deploy/html/images/pharmacy-08-00059-g001.png)
Pharmacy | Free Full-Text | Contrasting PTH Response of Denosumab Use in Dialysis Patients: A Report of 2 Cases
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ONTRUZANT safely and eff
![Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments - ScienceDirect Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0022283617305910-gr2.jpg)
Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments - ScienceDirect
![Effect of diabetes and 15 day administration of Met (500 mg kg À1 ),... | Download Scientific Diagram Effect of diabetes and 15 day administration of Met (500 mg kg À1 ),... | Download Scientific Diagram](https://www.researchgate.net/publication/324035559/figure/fig2/AS:608790114209793@1522158282523/Effect-of-diabetes-and-15-day-administration-of-Met-500-mg-kg-A1-Trop-1-Trop-2-or.png)
Effect of diabetes and 15 day administration of Met (500 mg kg À1 ),... | Download Scientific Diagram
![WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents](https://patentimages.storage.googleapis.com/65/8f/be/8cc6d9b44f2d24/imgf000024_0001.png)
WO2018170492A1 - Kappa opioid receptor antagonists and products and methods related thereto - Google Patents
![Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties | Journal of Medicinal Chemistry Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm301656h/asset/images/medium/jm-2012-01656h_0010.gif)
Design, Synthesis, and Pharmacological Characterization of N- and O-Substituted 5,6,7,8-Tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol Analogues: Novel 5-HT2A/5-HT2C Receptor Agonists with Pro-Cognitive Properties | Journal of Medicinal Chemistry
![Antidepressant-like Effect of Merazin Hydrate Depends on NO/ERK by Suppressing Its Downstream NF-κB or Nonactivating CREB/BDNF in Mouse Hippocampus | ACS Chemical Neuroscience Antidepressant-like Effect of Merazin Hydrate Depends on NO/ERK by Suppressing Its Downstream NF-κB or Nonactivating CREB/BDNF in Mouse Hippocampus | ACS Chemical Neuroscience](https://pubs.acs.org/cms/10.1021/acschemneuro.0c00246/asset/images/medium/cn0c00246_0004.gif)
Antidepressant-like Effect of Merazin Hydrate Depends on NO/ERK by Suppressing Its Downstream NF-κB or Nonactivating CREB/BDNF in Mouse Hippocampus | ACS Chemical Neuroscience
![Effect of diabetes and 15 day administration of Met (500 mg kg À1 ),... | Download Scientific Diagram Effect of diabetes and 15 day administration of Met (500 mg kg À1 ),... | Download Scientific Diagram](https://www.researchgate.net/publication/324035559/figure/fig3/AS:608790114222081@1522158282553/Effect-of-diabetes-and-15-day-administration-of-Met-500-mg-kg-A1-Trop-1-Trop-2-or.png)
Effect of diabetes and 15 day administration of Met (500 mg kg À1 ),... | Download Scientific Diagram
![Synthesis and in Vitro and in Vivo Activity of (−)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-Alkenyl-, -N-Alkynyl-, and -N-Cyanoalkyl-5,9-dimethyl-2'-hydroxy-6,7-benzomorphan Homologues | Journal of Medicinal Chemistry Synthesis and in Vitro and in Vivo Activity of (−)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-Alkenyl-, -N-Alkynyl-, and -N-Cyanoalkyl-5,9-dimethyl-2'-hydroxy-6,7-benzomorphan Homologues | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm000317+/asset/images/large/jm0003171n00001.jpeg)
Synthesis and in Vitro and in Vivo Activity of (−)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-Alkenyl-, -N-Alkynyl-, and -N-Cyanoalkyl-5,9-dimethyl-2'-hydroxy-6,7-benzomorphan Homologues | Journal of Medicinal Chemistry
![Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019) Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)](https://jnccn.org/view/journals/jnccn/17/11.5/full-jnccn20195034f1.jpg)
Patient Case Studies and Panel Discussion: Plasma Cell Neoplasms in: Journal of the National Comprehensive Cancer Network Volume 17 Issue 11.5 (2019)
![IJMS | Free Full-Text | Anti-Neuroinflammatory and Neuroprotective Effect of Intermedin B Isolated from the Curcuma longa L. via NF-κB and ROS Inhibition in BV2 Microglia and HT22 Hippocampal Cells IJMS | Free Full-Text | Anti-Neuroinflammatory and Neuroprotective Effect of Intermedin B Isolated from the Curcuma longa L. via NF-κB and ROS Inhibition in BV2 Microglia and HT22 Hippocampal Cells](https://www.mdpi.com/ijms/ijms-24-07390/article_deploy/html/images/ijms-24-07390-g001.png)